2 news items
Paladin Labs Announces Approval of WAKIX® (pitolisant hydrochloride tablets) For Use in Pediatric Patients in Canada
ENDPQ
28 Mar 24
. Di Francesco and other statements relating to regulatory, marketing and reimbursement
Endo Announces Confirmation of Plan of Reorganization
ENDPQ
19 Mar 24
unusual items; domestic and foreign health care and cost containment reforms, including government pricing, tax and reimbursement policies; technological
- Prev
- 1
- Next